Latest news
Loading news…
CymoGen Dx
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). New Windsor, New York, United States Founded 2010 51-100 employees For Profit
CymoGen Dx is a genomic diagnostic company engaged in the development and application of fluorescence-based DNA detection technologies.
CymoGen Dx was acquired by Biocare Medical in 2014.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- IT spend
- $30.23K
Company Info
- Founded
- 2010
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- New Windsor, New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Oct 3, 2014
- Closed
- Mar 9, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.3
- Trend (90d)
- -0.1
Key People at CymoGen Dx
Chief Medical Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to CymoGen Dx
Loading news…
FAQs about CymoGen Dx
People who checked this page also checked these
Browse the full Acquirezy directory.